Upstream Bio, Inc. (UPB) Stock Statistics & Valuation Metrics

Upstream Bio, Inc. has a market cap or net worth of $751.50M. The enterprise value is $517.82M.

Upstream Bio, Inc. has 53,793,700 shares outstanding. The number of shares has decreased by -2.65% in one year.

Upstream Bio, Inc.’s return on equity (ROE) is -0.13 and return on invested capital (ROIC) is -16.49%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Upstream Bio, Inc. had revenue of 2.37M and earned -62.81M in profits. Earnings per share was -1.49.

In the last 12 months, operating cash flow was -74.74M and capital expenditures -511.00K, giving a free cash flow of -75.25M billion.

Upstream Bio, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Upstream Bio, Inc. upcoming earnings date is ―, ―.

Upstream Bio, Inc. as a current ratio of 44.63, with Debt / Equity ratio of 0.38%

In the past 12 months, Upstream Bio, Inc. has paid 0.00 in taxes.

Upstream Bio, Inc. EV to EBITDA ratio is -6.69, with an EV/FCF ratio of -8.71.

Upstream Bio, Inc. has $431.38M in cash and marketable securities with $1.70M in debt, giving a net cash position of -$429.68M billion.

Gross margin is 100.00%, with operating margin of -3281.18%, and net profit margin of -2650.04%.

The average price target for Upstream Bio, Inc. is $55.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy